Transphorm Balance Sheet Health
Financial Health criteria checks 4/6
Transphorm has a total shareholder equity of $18.3M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $32.7M and $14.4M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$7.95m |
| Equity | US$18.25m |
| Total liabilities | US$14.41m |
| Total assets | US$32.66m |
Recent financial health updates
Recent updates
Transphorm: Deal Likely Done Even If Not Everyone Is Happy
Feb 07Revenues Tell The Story For Transphorm, Inc. (NASDAQ:TGAN)
May 17
Transphorm, Inc. (NASDAQ:TGAN) Just Reported And Analysts Have Been Cutting Their Estimates
Nov 17Transphorm bags ARPA-E contract for four-quadrant GaN switches
Aug 30Transphorm Non-GAAP EPS of -$0.08 in-line, revenue of $5.2M misses by $0.03M
Aug 15Transphorm: Turning Technology Into Revenue
Jul 28Financial Position Analysis
Short Term Liabilities: TGAN's short term assets ($21.0M) exceed its short term liabilities ($12.4M).
Long Term Liabilities: TGAN's short term assets ($21.0M) exceed its long term liabilities ($2.0M).
Debt to Equity History and Analysis
Debt Level: TGAN is debt free.
Reducing Debt: TGAN currently has no debt however we can't compare to 5 years ago as we have no data for that period.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: TGAN has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: TGAN has less than a year of cash runway if free cash flow continues to reduce at historical rates of 12.4% each year